A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women

Levent SARIYILDIZ, (Sağlık Bakanlığı, Dr. Faruk Sükan Doğum ve Çocuk Hastanesi, Konya, Türkiye)
Turan AKDAĞ (Konya Üniversitesi, Meram Tıp Fakültesi, Biyokimya Anabilim Dalı, Konya, Türkiye)
Journal of Clinical and Analytical Medicine
7 0
Yıl: 2013 Cilt: 4 Sayı: 3 Sayfa Aralığı: 241 - 244 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women

Öz:
Müllerian inhibe edici madde (MIS) olarak da adlandırılan anti-müllerian hormon (AMH), yumurtalıkta granüloza hücreleri tarafından üretilir ve Transforming growth β ailesi (TGF-β) ailesinin bir üyesi olarak bilinmektedir. Araştırmalar AMHnın over folikül gelişimi ve büyümesinde etkili olduğunu ve TGF-βailesinin diğer üyeleri ile aynı özellikleri sergilediğini göstermektedir. AMH,kadınların üreme çağında kritik bir öneme sahiptir. Henüz over rezervi saptanmalarıyla ilgili belli bir standardizasyon geliştirilmemiştir. Son bulgular over fonksiyonun belirlenmesinde, AMH ölçülmesini Folikül stimüle edici hormon (FSH)dan daha öne çıkarmaktadır.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Kadınlarda Over Rezervini ve Menopoz Yaşını Belirlemede Yeni Prediktör AMH (Anti-Müllerian Hormon)

Öz:
Anti-mullerian hormone (AMH), also termed Mullerian inhibiting substance(MIS), is produced in ovary by granulose cells and known as a member of theTGF- β superfamily. The researchers imply that AMH is associated with thevarious growth factors in development and growth of ovarian follicles, furthermore is exhibited the features of other TGF-β family members. AMH hasa critical importance in reproductive age of women. Certain standardizationhas not yet been developed in determing the ovarian reserve. Recent findingsreveal the importance of AMH in determining ovary function and, highlightthe importance of AMH than FSH.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Picon P. Action of the fetal testis on the development in vitro at müllerian duct in the rat Arc. Anat Micrise Morphol Exp 1983; 58 (1): 19.
  • 2. Pricad JY, Josso N. Purification of testicular Anti-Mülleran hormone, allowing di- rect visualization of pure glycoprotein and determination of yield and purification factor. Mol Cell Endocrinol 1984;34(1) : 23-29.
  • 3. di Clemente N, Ghaffari S, Pepinsky RB, Pieau C, Jossp N, Cate RL et al. Quan- titative and interspecific test for biological activity of anti-müllerian hormone: the fetal ovary aromatase assay. Dev 1992; 114: 721 – 727.
  • 4. Cate RL, Mattaliano RJ, Hession C et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 1986; 45: 685–698.
  • 5. Behringer RR. The invivo roks of müllerian inhibiting substance. Curr Top Dev Biol 1999; 29: 171- 187.
  • 6. di Clemente N, Wilson C, Foure E, Boussin L, Carmillo P, Tizard R, et al. Cloning expression and alternative splicing of the receptor for Anti-müllerian hormone. Mol endocrinol 1994; 8: 1006- 20.
  • 7. Massauge J. TGF- beta, signal transduation. Annurev Biochem 1998; 67: 753– 791.
  • 8. Behringer RR, Finegold MJ, Cate RL. Müllerian inhibiting substance function during mammalian sexual development. Cell 1994; 79: 415 – 425.
  • 9. Teixeria J, Maheswaran S, Donahoe PK. Müllerian inhibiting substanc, an instructive developmental hormone with diagnostic and possible therapeutic applications. Endoc Rev 2001; 22(5): 657-74.
  • 10. Matzuk MM, Burns KH, Viverios MM, Eppig JJ. Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 2002; 296(5576): 2178-80.
  • 11. Knight PG, Glister C. TGF-B super family members and ovarian follicle devolopment. Reproduction 2006; 132: 191-206.
  • 12. Hirobe S, He WW, Lee MMi, Donahoe PK. Müllerian inhibiting substance mes- senger ribonucleic acid expression in granulosa and sertoli cells coincides with their mitotic activity. Endocrinology 1992; 131: 854 – 862.
  • 13. Weenen C, Laveb J, Von Bergh A, Cranfield M, Grome NP, Witser JA et al. Anti-müllerian Hormone expression patter in the human ovary, potential implications for inital and acyclic follicle recruitment. Mol human Reprod 2004; 10(2) :77–83.
  • 14. Van Rooij IA, Broekmans FJ, te Velde ER, Fauser BCJM, Banesi LF, de Jong FH et al. Serum Anti-mullerian Hormone levels. a novel meausure of ovarian reserve. Hum Reprod 2002; 17: 3065 – 3071.
  • 15. Cupisti S, Dittrich R, Mueller A, Strick R, Stiegler E, Binder H et al. Correlation between anti-müllerian hormone inhibin B and activin A in follicular fluid in VF/CS patients for assessing the maturation and developmental patential of oocytes. E J Med Res 2007; 12(12) 604–608.
  • 16. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disap- pearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992; 7(10): 1342-6.
  • 17. Gougeon A. Regulation of ovarian follicular development primates: fact and hpotheses. Endoc Rev 1996; 17: 121 – 55.
  • 18. te Velde ER, Van Leusden HA. Hormonal treatment for the climacteric: al- levation of symptoms and prevention of past menopausal disease. Lanset 1994; 343:654-58.
  • 19. Gibaldi M. Prevention and treatment of asteoporosis; does the future belong to hormone replacement therapy? J Clin Pharmacol 1997; 37: 1087 – 99.
  • 20. Kesslak JP. Can estrogen play a significant role in the prevention of Alzheimer’s disease? Neural Transm 2002; Suppl 227 – 239.
  • 21. Baarends WM, Van helmond MJ, Post M. A novel member of the transmem- brane serine/ threonine kinase receptor family is specifally expressed in the go- nads and in mesenchymal cells adjacent to müllerian duct. Development 1994; 120: 189-197.
  • 22. Durlinger ALL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM et al. Anti-müllerian hormone attenuates the effects of FSH on follicle devlopment in the mouse ovary. Endocrinology 2001; 142 (11): 4891–99.
  • 23. Durlinger ALL, Visser JA, Themmen APN. Regulation of ovarion function; The role of Anti-Müllerian Hormone. Reproduction 2002; 124: 601 – 609.
  • 24. Durlinger ALL, Kramer P, Karels B, de jong FH, Uilenbreek JT, Themmen AP. Control of priamordial follicle recruitment by anti-müllerian hormone in the mouse ovary. Endocrionology 1999; 140: 5789–96.
  • 25. Christine LC, Yong S, Amy GB. Relationship between serum mullerian inhibiting substance and other reproductive hormones in untreated women with PCOS and normal women. Fertility and Sterility 2002; 77(1): 141 – 146.
  • 26. Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehad S et al. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 2007; 92: 240–245.
  • 27. Cook CL, Siow Y, Taulor S, Fallat ME. Serum müllerian inhibiting substance levels during normal menstrual cycles. Fertil and Steril 2000; 73: 859 – 861.
  • 28. Pigny P, Jonard S, Robert Y, Dewailly D. Serum Anti-Müllerian Hormone as surrogate for antral follicle count for definition of Pcos. J Clin Endocrinol Metab 2006; 91: 941-45.
  • 29. Petermann TS, Codner E, Maliqueo M, Echiburu B, Hitschfeld C, Crisosto N et al. İncreased Anti-mullerian Hormone Serum Concentrations in prepubertal doughters of women with pCOS. Clin E and Metab 2006; 91(8): 3105 – 3109.
  • 30. Crisosto N, Codner E, Maliquen M, Echiburu B, Sanchez F, Petermann T. Anti-mullerian Hormone levels in prepubertal doughters of women with polycystic Ovary Syndrome. J Clin Metab 2007; 92(7): 2739 – 2743.
  • 31. Visser J, de Jong F, Laven J, Themmen A. Anti-müllerian hormone: a new marker ovarion function. Reproduction 2006; 131(1): 1-9.
  • 32. la Marca A, Giulini R, Orvieto R, Volpe A. Anti Müllerian Hormone concentra- tions in maternal serum during pregnancy. Human Reproduction 2005; 20: 1569- 72.
  • 33. Kevenaar ME, Themmen AP, Laven JS, Wanschoor NM, Lips P, Pols HA et al. Anti Müllerian hormone and Anti Müllerian Hormone Type–2 Receptor polymorphism are asociated with follicular phase estradiol levels in normo ovulatory women. Hum Reprod 2007; 22: 1547-1554.
  • 34. laPolt PS, Matt DW, Lu JK. Progesterone implants delay age related declines in regular estrous cyclicity and the ovarian follicular reserve in Long-Evans Rats. Biol Reprod 1998; 59: 197 – 201.
  • 35. Freaman EW, Gracia CR, Sammel MD, Lin H, Lim LC, Starus JF. Association of anti-müllerian hormone levels with obesity in late reproductive age women. Fertil and Steril 2007; 87 (1): 101–106.
  • 36. Hudson PL, Dougas I, Donahoe PK, Cate RL, Epstein J, Pepinsky RB et al. An İmmunoassay to detect human mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 1990; 76: 16 – 22.
  • 37. Josso N, Legeai L, Forest MG, Chaussain JL, Brauner R. An enzyme linked im- munoassay for anti-mullerian hormone: a new tool for the evaluation of testicular function in infants and children. J Clin Endocrinol Metab 1990; 70: 13 – 27.
  • 38. Gruijters MJG, Visser JA, Durlinger AL, Themmen AP. Anti- müllerian hormone and it’s role in ovarian function. Mol Cell Endocrinol 2003; 211 (1–2): 85–90.
  • 39. Lekamge DN, Barry M, Kolo M, Lane M, Gilchrist RB, Tremellen KP: Antimüllerian hormone as a predictor of IVF outcome. Reprod Biomed online 2007; 14(5) : 602-610.
  • 40. Bayramoğlu ZB: Anti-Müllerian Hormonun IVF sikluslarında over rezervini belirlemedeki rolü Uzmanlık Tezi, 2005–35.
APA SARIYILDIZ L, AKDAĞ T (2013). A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women. , 241 - 244.
Chicago SARIYILDIZ LEVENT,AKDAĞ TURAN A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women. (2013): 241 - 244.
MLA SARIYILDIZ LEVENT,AKDAĞ TURAN A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women. , 2013, ss.241 - 244.
AMA SARIYILDIZ L,AKDAĞ T A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women. . 2013; 241 - 244.
Vancouver SARIYILDIZ L,AKDAĞ T A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women. . 2013; 241 - 244.
IEEE SARIYILDIZ L,AKDAĞ T "A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women." , ss.241 - 244, 2013.
ISNAD SARIYILDIZ, LEVENT - AKDAĞ, TURAN. "A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women". (2013), 241-244.
APA SARIYILDIZ L, AKDAĞ T (2013). A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women. Journal of Clinical and Analytical Medicine, 4(3), 241 - 244.
Chicago SARIYILDIZ LEVENT,AKDAĞ TURAN A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women. Journal of Clinical and Analytical Medicine 4, no.3 (2013): 241 - 244.
MLA SARIYILDIZ LEVENT,AKDAĞ TURAN A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women. Journal of Clinical and Analytical Medicine, vol.4, no.3, 2013, ss.241 - 244.
AMA SARIYILDIZ L,AKDAĞ T A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women. Journal of Clinical and Analytical Medicine. 2013; 4(3): 241 - 244.
Vancouver SARIYILDIZ L,AKDAĞ T A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women. Journal of Clinical and Analytical Medicine. 2013; 4(3): 241 - 244.
IEEE SARIYILDIZ L,AKDAĞ T "A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women." Journal of Clinical and Analytical Medicine, 4, ss.241 - 244, 2013.
ISNAD SARIYILDIZ, LEVENT - AKDAĞ, TURAN. "A New Predictor AMH (anti-müllerian hormone) to Determining Ovarian Reserve and Menoposual Aging in the Women". Journal of Clinical and Analytical Medicine 4/3 (2013), 241-244.
Sayfa Oluşturulma Tarihi
09-05-2024 19:4

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları